AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial.

Florian HeitzChristian MarthStéphanie HenryAlexander ReussDavid CibulaLydia Gaba GarciaNicoletta ColomboBarbara SchmalfeldNikolaus de GregorioPauline WimbergerAnnette HasenburgJalid SehouliMartina Gropp-MeierPhilip C SchoutenEric HahnenJan HaukeSandra PolleisPhilipp Harter

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)

NCT05009082; EudraCT Number: 2021-001271-16.

Keyphrases

phase iii
double blind
placebo controlled
open label
clinical trial
phase ii
phase ii study
locally advanced
study protocol
metastatic colorectal cancer
cross sectional
metastatic breast cancer
squamous cell carcinoma
rectal cancer